Global Loop Diuretic Market – Industry Trends and Forecast to 2030

Global Loop Diuretic Market, By Drugs (Ethacrynic Acid, Furosemide, Torsemide, Bumetanide, Others), Indication (Edema, Kidney Failure, Nephrotic Syndrome, Liver Cirrhosis, Heart Failure, High Blood Pressure, Others), Route of Administration (Oral, Intravenous), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Loop Diuretic Market Analysis and Size

The demand for the loop diuretic market has increased significantly because of advancements in technology, high incidence of renal diseases, and increasing geriatric population will boost the market growth. Moreover, increasing patient population and lack of proper treatment will act as an opportunity for market growth. However, post-treatment complications, discontinuation of some drugs, and adverse side effects after taking drugs will hamper the market growth.

Data Bridge Market Research analyses that the global loop diuretic market which was USD 2,472.84 million in 2022, is expected to reach USD 3,021.80 million by 2030, and is expected to undergo a CAGR of 2.6% during the forecast period 2023-2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Loop Diuretic Market Scope and Segmentation

Market Definition

A loop diuretic is a type of medication commonly used to treat conditions such as high blood pressure (hypertension), heart failure, edema (fluid retention), and certain kidney disorders. It belongs to a class of diuretics, which are drugs that promote diuresis, the increased production of urine, by acting on the kidneys. Loop diuretics specifically target a part of the kidney known as the loop of Henle, which plays a crucial role in reabsorbing water and electrolytes (sodium, potassium, chloride) back into the bloodstream. By inhibiting the reabsorption of sodium and chloride in this segment of the kidney, loop diuretics help increase the excretion of these electrolytes in urine, ultimately leading to a reduction in extracellular fluid volume and a decrease in blood pressure.

Global Loop Diuretic Market Dynamics

Drivers

• Growing Prevalence of Neuropathic Pain Disorders

The rising incidence of neuropathic pain disorders globally is a significant driver for the global loop diuretic market. Neuropathic pain, often associated with conditions such as diabetic neuropathy, post-herpetic neuralgia, and trigeminal neuralgia, necessitates effective pain management. Loop Diuretic has proven efficacy in managing neuropathic pain, driving its demand and adoption.

• Expanding Applications and Off-Label Usage

Loop Diuretic's versatility in treating various medical conditions beyond its initial intended use, such as anxiety disorders, migraines, and restless legs syndrome, contributes to market growth. Physicians and healthcare practitioners increasingly prescribe loop diuretic off-label for these conditions, broadening its market reach and fueling demand.

Opportunity

• Rising Awareness and Education Initiatives

There is a substantial opportunity for market growth through increased awareness and educational initiatives regarding loop diuretic's benefits, optimal usage, and potential side effects. Educating healthcare professionals, patients, and caregivers about the appropriate use of loop diuretic, its efficacy in managing various conditions, and safety precautions can enhance its acceptance and adoption. This educational approach can not only expand the market but also foster responsible usage, which is crucial in ensuring positive outcomes and mitigating potential risks.

Restraint/Challenge

• Concerns Regarding Abuse and Dependency

One significant restraint for the global loop diuretic market is the rising concern regarding its potential for abuse and dependency. Reports of misuse and addiction, particularly when combined with other substances like opioids, have raised regulatory scrutiny and led to tighter control and monitoring of loop diuretic prescriptions. This has the potential to limit its usage and impact the overall market growth.

This global loop diuretic market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global loop diuretic market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

• In September 2023, Pfizer Inc. and BioNTech SE have announced that they received approval from the U.S. Food and Drug Administration (FDA) for their supplemental Biologics License Application (COMIRNATY 2023-2024 Formulation). This approval covers individuals aged 12 and above, and it includes emergency use authorization for children aged 6 months to 11 years, specifically for their Omicron XBB.1.5-adapted monovalent COVID-19 vaccine. The current vaccine season's recommendation is for a single dose for most individuals aged 5 and older. However, children under 5 years old may qualify for additional doses of this season's vaccine if they have not already completed a three-dose series with earlier formulations of a COVID-19 vaccine.

 Global Loop Diuretic Market Scope

The global loop diuretic market is segmented on the basis of drugs, indication, route of administration, end-users, and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drugs

• Ethacrynic Acid
• Furosemide
• Torsemide
• Bumetanide
• Others

 Application

• Epilepsy
• Neuropathic Pain
• Restless Legs Syndrome

Route of Administration

• Oral
• Parenteral
• Intravenous

Mode of Purchase

• Prescription
• Retail
• Over the counter

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Global Loop Diuretic Market Regional Analysis/Insights

The global loop diuretic market is analysed and market size insights and trends are provided by country, product type, application, route of administration, mode of purchase and distribution channel as referenced above.

The countries covered in the global loop diuretic market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, and Rest of Middle East and Africa

North America dominates and register the highest growth rate in the global loop diuretic market due to rise in the surge in the approvals of products for the treatment and rise in the initiatives taken by the government and pharmaceutical organizations to spread awareness regarding the disease in this region.

Asia-Pacific is the expected region in terms of growth in global loop diuretic market during the forecasted period of 2023 to 2030, due to rise in the prevalence of acute lymphocytic/lymphoblastic leukemia (ALL) in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the Market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The global loop diuretic market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for global loop diuretic market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the global loop diuretic market. The data is available for historic period 2015-2020.

Competitive Landscape and Global Loop Diuretic Market Share Analysis

The global loop diuretic market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global loop diuretic market.

Some of the major players operating in the global loop diuretic market are:

• Amgen Inc. (U.S.)
• Bristol-Myers Squibb Company (U.S.)
• Erytech Pharma (France)
• Novartis AG (Switzerland)
• Pfizer Inc. (U.S.)
• Rare Disease Therapeutics, Inc. (U.S.)
• Sanofi (France)
• Spectrum Pharmaceuticals, Inc. (U.S.)
• Takeda Pharmaceutical Company Limited (Japan)
• Genmab A/S (Denmark)
• Baxter (U.S.)
• Gilead Sciences, Inc. (U.S.)
• CELGENE CORPORATION (U.S.)
• Eisai Co., Ltd. (Japan)
• SymBio Pharmaceuticals Limited (Japan)
• Kiadis Pharma (Netherlands)
• OBI Pharma (Taiwan)
• Astellas Pharma Inc. (Japan)
• Medexus Pharma, Inc. (Canada)